Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial

Autor: Deplanque, Gaël, Gervais, Radj, Vergnenegre, Alain, Falchero, Lionel, Souquet, Pierre-Jean, Chavaillon, Jean-Michel, Taviot, Bruno, Fraboulet, Ghislaine, Saal, Hakim, Robert, Caroline, Chosidow, Olivier
Zdroj: In Journal of the American Academy of Dermatology June 2016 74(6):1077-1085
Databáze: ScienceDirect
Externí odkaz: